4124 SEX AND CARDIOVASCULAR DISEASE IN STAGE G2-5 CKD PATIENTS

Abstract Background and Aims Male sex is considered a major risk factor for cardiovascular (CV) disease in the general population, but the role of this factor in the high risk for CV disease in the pre-dialysis CKD population is still debated. Methods We tested the relationship between sex and fatal...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:Nephrology, dialysis, transplantation dialysis, transplantation, 2023-06, Vol.38 (Supplement_1)
Hauptverfasser: Mallamaci, Francesca, Provenzano, Pasquale Fabio, Parlongo, Giovanna, Leonardis, Daniela, Caridi, Graziella, Marino, Francesco, D'arrigo, Graziella, Tripepi, Giovanni Luigi, Zoccali, Carmine
Format: Artikel
Sprache:eng
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
container_end_page
container_issue Supplement_1
container_start_page
container_title Nephrology, dialysis, transplantation
container_volume 38
creator Mallamaci, Francesca
Provenzano, Pasquale Fabio
Parlongo, Giovanna
Leonardis, Daniela
Caridi, Graziella
Marino, Francesco
D'arrigo, Graziella
Tripepi, Giovanni Luigi
Zoccali, Carmine
description Abstract Background and Aims Male sex is considered a major risk factor for cardiovascular (CV) disease in the general population, but the role of this factor in the high risk for CV disease in the pre-dialysis CKD population is still debated. Methods We tested the relationship between sex and fatal and non-fatal major CV events (myocardial infarction, heart failure, arrhythmia, angina, stroke, transient ischemic attack, peripheral vascular disease, major arterial or venous thrombotic episodes and sudden death) in a cohort including 759 stage 2-5 CKD consecutively recruited from 22 Nephrology units in southern Italy between October 2005 and September 2008. After the initial assessment, patients were followed up for a median time of 36 months (range 0.3–48 months). Results Four hundred fifty-five patients were males (60%). The proportion of smokers was about 4 times higher in males (71.4%) than in females (17.4%). Males and females differed in the prevalence of diabetes (38.5% versus 29.6%) and the frequency of background CV comorbidities (35.6% versus 19.7%, P
doi_str_mv 10.1093/ndt/gfad063c_4124
format Article
fullrecord <record><control><sourceid>oup_cross</sourceid><recordid>TN_cdi_crossref_primary_10_1093_ndt_gfad063c_4124</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><oup_id>10.1093/ndt/gfad063c_4124</oup_id><sourcerecordid>10.1093/ndt/gfad063c_4124</sourcerecordid><originalsourceid>FETCH-LOGICAL-c1224-a8267a00a0b550eb096c447dd56bdda305b2557ed51a0109fdac9a5fc9ced8d73</originalsourceid><addsrcrecordid>eNqNkMFKxDAYhIMoWFcfwFsewLp_0qRpLkJoYy2Wrmy64i2kSSuKukurB9_eLuvFm6e5fDMwH0KXBK4JyGT5ET6Xz4MLkCbeMkLZEYoISyGmScaPUTQzJAYO8hSdTdMrAEgqRIRu9iw2-gmrpsC5WhfV6lGZfFOrNS4qo5XRuGqwaVWpcUljjvP7Aj-ottJNa87RyeDepv7iNxdoc6vb_C6uV2WVqzr2hFIWu4ymwgE46DiHvgOZesZECDztQnAJ8I5yLvrAiYP5zxCcl44PXvo-ZEEkC0QOu37cTtPYD3Y3vry78dsSsHsBdhZg_wiYO1eHzvZr9w_8B-cLWFo</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype></control><display><type>article</type><title>4124 SEX AND CARDIOVASCULAR DISEASE IN STAGE G2-5 CKD PATIENTS</title><source>Free E-Journal (出版社公開部分のみ)</source><source>Alma/SFX Local Collection</source><source>Oxford Journals</source><creator>Mallamaci, Francesca ; Provenzano, Pasquale Fabio ; Parlongo, Giovanna ; Leonardis, Daniela ; Caridi, Graziella ; Marino, Francesco ; D'arrigo, Graziella ; Tripepi, Giovanni Luigi ; Zoccali, Carmine</creator><creatorcontrib>Mallamaci, Francesca ; Provenzano, Pasquale Fabio ; Parlongo, Giovanna ; Leonardis, Daniela ; Caridi, Graziella ; Marino, Francesco ; D'arrigo, Graziella ; Tripepi, Giovanni Luigi ; Zoccali, Carmine</creatorcontrib><description>Abstract Background and Aims Male sex is considered a major risk factor for cardiovascular (CV) disease in the general population, but the role of this factor in the high risk for CV disease in the pre-dialysis CKD population is still debated. Methods We tested the relationship between sex and fatal and non-fatal major CV events (myocardial infarction, heart failure, arrhythmia, angina, stroke, transient ischemic attack, peripheral vascular disease, major arterial or venous thrombotic episodes and sudden death) in a cohort including 759 stage 2-5 CKD consecutively recruited from 22 Nephrology units in southern Italy between October 2005 and September 2008. After the initial assessment, patients were followed up for a median time of 36 months (range 0.3–48 months). Results Four hundred fifty-five patients were males (60%). The proportion of smokers was about 4 times higher in males (71.4%) than in females (17.4%). Males and females differed in the prevalence of diabetes (38.5% versus 29.6%) and the frequency of background CV comorbidities (35.6% versus 19.7%, P&lt;0.001). Waist circumference (100.9±12.4 versus 96±14.1 cm), eGFR (37.5±13.4 versus 33±12.7 ml/min/1.73 m2), 24-hour urinary protein excretion (median: 0.7 g/24h, IQR: 0.2-1.6 g/24h versus 0.5, IQR: 0.2-1.2 g/24 h), and haemoglobin (13.4±1.9 versus 12.0±1.4 g/dL) were higher in males than in females. Serum phosphate (3.6±0.75 versus 3.9±0.75 mg/dL), hs-CRP (median; 2.2 mg/dl, IQR: 1-4.7mg/dl versus 2.8 mg/dl, IQR: 1.2-6.4 mg/dl) and total cholesterol (178.3±42.1 versus 198.8±45.6 mg/dl) were lower in males than in females. During follow-up, 42 patients died, and 118 had fatal and non-fatal CV events. On univariate Cox regression analyses, male gender failed to be associated with all-cause mortality but was strongly related to the incidence rate of fatal and non-fatal major CV events [HR 1.75, 95% CI: 1.18-2.60, P=0.006]. Data adjustment for a series of major potential confounders did not materially affect the strength of this relationship [HR:1.78, 95% CI: 1.03-3.09]. Further analysis testing the effect of age on major CV outcomes by gender showed an effect modification by this risk factor on the same outcome (P=0.037) because the hazard ratio of male versus female CV events increased progressively with ageing (Figure 1). Figure 1: Conclusion The excess risk for CV mortality by the male gender in the general population holds in stage G2-5 CKD patients. Age is a modifier for the excess risk for CV events in CKD patients because the risk excess of the male gender increases linearly across a wide age spectrum in CKD patients.</description><identifier>ISSN: 0931-0509</identifier><identifier>EISSN: 1460-2385</identifier><identifier>DOI: 10.1093/ndt/gfad063c_4124</identifier><language>eng</language><publisher>Oxford University Press</publisher><ispartof>Nephrology, dialysis, transplantation, 2023-06, Vol.38 (Supplement_1)</ispartof><rights>The Author(s) 2023. Published by Oxford University Press on behalf of the ERA. 2023</rights><lds50>peer_reviewed</lds50><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><link.rule.ids>314,780,784,27924,27925</link.rule.ids></links><search><creatorcontrib>Mallamaci, Francesca</creatorcontrib><creatorcontrib>Provenzano, Pasquale Fabio</creatorcontrib><creatorcontrib>Parlongo, Giovanna</creatorcontrib><creatorcontrib>Leonardis, Daniela</creatorcontrib><creatorcontrib>Caridi, Graziella</creatorcontrib><creatorcontrib>Marino, Francesco</creatorcontrib><creatorcontrib>D'arrigo, Graziella</creatorcontrib><creatorcontrib>Tripepi, Giovanni Luigi</creatorcontrib><creatorcontrib>Zoccali, Carmine</creatorcontrib><title>4124 SEX AND CARDIOVASCULAR DISEASE IN STAGE G2-5 CKD PATIENTS</title><title>Nephrology, dialysis, transplantation</title><description>Abstract Background and Aims Male sex is considered a major risk factor for cardiovascular (CV) disease in the general population, but the role of this factor in the high risk for CV disease in the pre-dialysis CKD population is still debated. Methods We tested the relationship between sex and fatal and non-fatal major CV events (myocardial infarction, heart failure, arrhythmia, angina, stroke, transient ischemic attack, peripheral vascular disease, major arterial or venous thrombotic episodes and sudden death) in a cohort including 759 stage 2-5 CKD consecutively recruited from 22 Nephrology units in southern Italy between October 2005 and September 2008. After the initial assessment, patients were followed up for a median time of 36 months (range 0.3–48 months). Results Four hundred fifty-five patients were males (60%). The proportion of smokers was about 4 times higher in males (71.4%) than in females (17.4%). Males and females differed in the prevalence of diabetes (38.5% versus 29.6%) and the frequency of background CV comorbidities (35.6% versus 19.7%, P&lt;0.001). Waist circumference (100.9±12.4 versus 96±14.1 cm), eGFR (37.5±13.4 versus 33±12.7 ml/min/1.73 m2), 24-hour urinary protein excretion (median: 0.7 g/24h, IQR: 0.2-1.6 g/24h versus 0.5, IQR: 0.2-1.2 g/24 h), and haemoglobin (13.4±1.9 versus 12.0±1.4 g/dL) were higher in males than in females. Serum phosphate (3.6±0.75 versus 3.9±0.75 mg/dL), hs-CRP (median; 2.2 mg/dl, IQR: 1-4.7mg/dl versus 2.8 mg/dl, IQR: 1.2-6.4 mg/dl) and total cholesterol (178.3±42.1 versus 198.8±45.6 mg/dl) were lower in males than in females. During follow-up, 42 patients died, and 118 had fatal and non-fatal CV events. On univariate Cox regression analyses, male gender failed to be associated with all-cause mortality but was strongly related to the incidence rate of fatal and non-fatal major CV events [HR 1.75, 95% CI: 1.18-2.60, P=0.006]. Data adjustment for a series of major potential confounders did not materially affect the strength of this relationship [HR:1.78, 95% CI: 1.03-3.09]. Further analysis testing the effect of age on major CV outcomes by gender showed an effect modification by this risk factor on the same outcome (P=0.037) because the hazard ratio of male versus female CV events increased progressively with ageing (Figure 1). Figure 1: Conclusion The excess risk for CV mortality by the male gender in the general population holds in stage G2-5 CKD patients. Age is a modifier for the excess risk for CV events in CKD patients because the risk excess of the male gender increases linearly across a wide age spectrum in CKD patients.</description><issn>0931-0509</issn><issn>1460-2385</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2023</creationdate><recordtype>article</recordtype><recordid>eNqNkMFKxDAYhIMoWFcfwFsewLp_0qRpLkJoYy2Wrmy64i2kSSuKukurB9_eLuvFm6e5fDMwH0KXBK4JyGT5ET6Xz4MLkCbeMkLZEYoISyGmScaPUTQzJAYO8hSdTdMrAEgqRIRu9iw2-gmrpsC5WhfV6lGZfFOrNS4qo5XRuGqwaVWpcUljjvP7Aj-ottJNa87RyeDepv7iNxdoc6vb_C6uV2WVqzr2hFIWu4ymwgE46DiHvgOZesZECDztQnAJ8I5yLvrAiYP5zxCcl44PXvo-ZEEkC0QOu37cTtPYD3Y3vry78dsSsHsBdhZg_wiYO1eHzvZr9w_8B-cLWFo</recordid><startdate>20230614</startdate><enddate>20230614</enddate><creator>Mallamaci, Francesca</creator><creator>Provenzano, Pasquale Fabio</creator><creator>Parlongo, Giovanna</creator><creator>Leonardis, Daniela</creator><creator>Caridi, Graziella</creator><creator>Marino, Francesco</creator><creator>D'arrigo, Graziella</creator><creator>Tripepi, Giovanni Luigi</creator><creator>Zoccali, Carmine</creator><general>Oxford University Press</general><scope>AAYXX</scope><scope>CITATION</scope></search><sort><creationdate>20230614</creationdate><title>4124 SEX AND CARDIOVASCULAR DISEASE IN STAGE G2-5 CKD PATIENTS</title><author>Mallamaci, Francesca ; Provenzano, Pasquale Fabio ; Parlongo, Giovanna ; Leonardis, Daniela ; Caridi, Graziella ; Marino, Francesco ; D'arrigo, Graziella ; Tripepi, Giovanni Luigi ; Zoccali, Carmine</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c1224-a8267a00a0b550eb096c447dd56bdda305b2557ed51a0109fdac9a5fc9ced8d73</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2023</creationdate><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Mallamaci, Francesca</creatorcontrib><creatorcontrib>Provenzano, Pasquale Fabio</creatorcontrib><creatorcontrib>Parlongo, Giovanna</creatorcontrib><creatorcontrib>Leonardis, Daniela</creatorcontrib><creatorcontrib>Caridi, Graziella</creatorcontrib><creatorcontrib>Marino, Francesco</creatorcontrib><creatorcontrib>D'arrigo, Graziella</creatorcontrib><creatorcontrib>Tripepi, Giovanni Luigi</creatorcontrib><creatorcontrib>Zoccali, Carmine</creatorcontrib><collection>CrossRef</collection><jtitle>Nephrology, dialysis, transplantation</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Mallamaci, Francesca</au><au>Provenzano, Pasquale Fabio</au><au>Parlongo, Giovanna</au><au>Leonardis, Daniela</au><au>Caridi, Graziella</au><au>Marino, Francesco</au><au>D'arrigo, Graziella</au><au>Tripepi, Giovanni Luigi</au><au>Zoccali, Carmine</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>4124 SEX AND CARDIOVASCULAR DISEASE IN STAGE G2-5 CKD PATIENTS</atitle><jtitle>Nephrology, dialysis, transplantation</jtitle><date>2023-06-14</date><risdate>2023</risdate><volume>38</volume><issue>Supplement_1</issue><issn>0931-0509</issn><eissn>1460-2385</eissn><abstract>Abstract Background and Aims Male sex is considered a major risk factor for cardiovascular (CV) disease in the general population, but the role of this factor in the high risk for CV disease in the pre-dialysis CKD population is still debated. Methods We tested the relationship between sex and fatal and non-fatal major CV events (myocardial infarction, heart failure, arrhythmia, angina, stroke, transient ischemic attack, peripheral vascular disease, major arterial or venous thrombotic episodes and sudden death) in a cohort including 759 stage 2-5 CKD consecutively recruited from 22 Nephrology units in southern Italy between October 2005 and September 2008. After the initial assessment, patients were followed up for a median time of 36 months (range 0.3–48 months). Results Four hundred fifty-five patients were males (60%). The proportion of smokers was about 4 times higher in males (71.4%) than in females (17.4%). Males and females differed in the prevalence of diabetes (38.5% versus 29.6%) and the frequency of background CV comorbidities (35.6% versus 19.7%, P&lt;0.001). Waist circumference (100.9±12.4 versus 96±14.1 cm), eGFR (37.5±13.4 versus 33±12.7 ml/min/1.73 m2), 24-hour urinary protein excretion (median: 0.7 g/24h, IQR: 0.2-1.6 g/24h versus 0.5, IQR: 0.2-1.2 g/24 h), and haemoglobin (13.4±1.9 versus 12.0±1.4 g/dL) were higher in males than in females. Serum phosphate (3.6±0.75 versus 3.9±0.75 mg/dL), hs-CRP (median; 2.2 mg/dl, IQR: 1-4.7mg/dl versus 2.8 mg/dl, IQR: 1.2-6.4 mg/dl) and total cholesterol (178.3±42.1 versus 198.8±45.6 mg/dl) were lower in males than in females. During follow-up, 42 patients died, and 118 had fatal and non-fatal CV events. On univariate Cox regression analyses, male gender failed to be associated with all-cause mortality but was strongly related to the incidence rate of fatal and non-fatal major CV events [HR 1.75, 95% CI: 1.18-2.60, P=0.006]. Data adjustment for a series of major potential confounders did not materially affect the strength of this relationship [HR:1.78, 95% CI: 1.03-3.09]. Further analysis testing the effect of age on major CV outcomes by gender showed an effect modification by this risk factor on the same outcome (P=0.037) because the hazard ratio of male versus female CV events increased progressively with ageing (Figure 1). Figure 1: Conclusion The excess risk for CV mortality by the male gender in the general population holds in stage G2-5 CKD patients. Age is a modifier for the excess risk for CV events in CKD patients because the risk excess of the male gender increases linearly across a wide age spectrum in CKD patients.</abstract><pub>Oxford University Press</pub><doi>10.1093/ndt/gfad063c_4124</doi><oa>free_for_read</oa></addata></record>
fulltext fulltext
identifier ISSN: 0931-0509
ispartof Nephrology, dialysis, transplantation, 2023-06, Vol.38 (Supplement_1)
issn 0931-0509
1460-2385
language eng
recordid cdi_crossref_primary_10_1093_ndt_gfad063c_4124
source Free E-Journal (出版社公開部分のみ); Alma/SFX Local Collection; Oxford Journals
title 4124 SEX AND CARDIOVASCULAR DISEASE IN STAGE G2-5 CKD PATIENTS
url https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2024-12-28T09%3A16%3A40IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-oup_cross&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=4124%20SEX%20AND%20CARDIOVASCULAR%20DISEASE%20IN%20STAGE%20G2-5%20CKD%20PATIENTS&rft.jtitle=Nephrology,%20dialysis,%20transplantation&rft.au=Mallamaci,%20Francesca&rft.date=2023-06-14&rft.volume=38&rft.issue=Supplement_1&rft.issn=0931-0509&rft.eissn=1460-2385&rft_id=info:doi/10.1093/ndt/gfad063c_4124&rft_dat=%3Coup_cross%3E10.1093/ndt/gfad063c_4124%3C/oup_cross%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_id=info:pmid/&rft_oup_id=10.1093/ndt/gfad063c_4124&rfr_iscdi=true